LuerJack in Norway - ConceptoMed AS and Vingmed AS signed a marketing, sales and distribution agreement for the hospital market

Press Releases   •   Nov 06, 2017 15:16 GMT

ConceptoMed AS is delighted to announce a new partner for the Norwegian hospital market. We have entered into a distribution agreement with Vingmed AS granting exclusive rights for marketing, sales and distribution of the LuerJack syringes in the hospital market in Norway.

LuerJack Lock - US FDA 510(k) cleared

Press Releases   •   Sep 11, 2017 15:24 BST

ConceptoMed AS has received FDA 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the LuerJack Slip syringes and the first LuerJack Lock 10ml syringe.

Chinese Patent issued for LuerJack

Press Releases   •   Apr 06, 2017 12:41 BST

On the 14th of February 2017, the Chinese Patent and Trademark office issued an official document granting the Chinese patent for LuerJack. ConceptoMed’s strategy to protect our intellectual property rights (IPR) remains unchanged and strong. Along with other markets already protected, such as Europe, the US, Australia and Mexico, protection in Asia is now following.

US FDA 510(k) Clearance for Luer-Jack® Slip syringe

Press Releases   •   Jan 13, 2017 16:32 GMT

ConceptoMed AS received FDA 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the first size of the Luer-Jack® syringe.

Luer-Jack secures Sterigenics Sterilization Services Agreement

Press Releases   •   Dec 22, 2016 11:35 GMT

In December 2016, ConceptoMed have entered into important collaborations with suppliers of sterilization services (Sterigenics) and logistics & healthcare warehousing services (DSV Logistics) to secure the global strategy for ConceptoMed and Luer-Jack.

ConceptoMed named "Company of the Year 2016" of Norwegian Medtech Cluster

News   •   Dec 18, 2016 15:56 GMT

On Thursday 8th of December 2016, ConceptoMed was named Company of the Year 2016 among approx 190 members of Oslo Medtech, a health technology cluster dedicated to accelerate and support the development of new medtech and eHealth products, services and innovative solutions for the Norwegian and global health care market.

Luer-Jack high-volume production agreement with AB Euroform MediPharm, Sweden

Press Releases   •   Oct 31, 2016 11:01 GMT

On the 28th of October 2016, ConceptoMed and AB Euroform MediPharm entered into an agreement for high-volume capacity manufacturing for Luer-Jack. Euroform MediPharm is a ISO 13485 certified long-term partner within development and production of polymer products for world class customers in Pharmaceutical and Medical Technology industries.

ConceptoMed obtains ISO 13485 certification

Press Releases   •   Sep 12, 2016 15:25 BST

ConceptoMed is proud to announce that it successfully passed the ISO 13485 quality assurance audit, and was issued the international ISO 13485 certificate by SP, our Notified Body.

European and Australian Patent Issued for Luer-Jack

Press Releases   •   Sep 09, 2016 06:04 BST

On the 31st of August 2016, the European Patent Office issued an official document granting the European patent for Luer-Jack. IP Australia, the Australian Government agency that administers intellectual property (IP) rights and legislation relating to patents, issued an official document granting the Australian patent for Luer-Jack - also on the 31st of August 2016.

ConceptoMed named in Disrupt 100 - Index of Disruptive Businesses Worldwide

Press Releases   •   May 25, 2016 10:40 BST

ConceptoMed proudly announce being named in the Disrupt 100 - a bi-annual Tällt Ventures publication celebrating the businesses with the most potential to influence, change or create new global markets. ConceptoMed were selected from over 1 million global startups and corporate ventures and judged by a selection of global brands.

Images & Videos 1 image, 1 video

Contacts 1 contact

About ConceptoMed

Tribute to Simplicity!

ConceptoMed AS is an ambitious medtech company serving the global market with innovative product categories and unique proprietary technology. We create smart medtech systems that empower smart healthcare professionals and improve patient care. Excellence through simplicity is our code. We are brave, curious and dedicated. We simply care. For more information on the company, see www.conceptomed.com - Follow us on MyNewsdesk and LinkedIn.

The ConceptoMed technology is widely patent protected throughout the world, currently with almost 70 patents (granted and pending) from almost 20 patent families.

Address

  • ConceptoMed
  • Hattvikveien 2
  • 8373 Ballstad
  • Norway